| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.29B | 5.33B | 5.69B | 5.17B | 3.67B | 2.17B |
| Gross Profit | 1.97B | 2.06B | 2.17B | 1.78B | 1.30B | 757.73M |
| EBITDA | 1.46B | 1.52B | 1.65B | 1.13B | 767.24M | 580.62M |
| Net Income | 1.04B | 1.08B | 1.20B | 883.16M | 551.74M | 425.88M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 8.15B | 5.48B | 4.22B | 3.39B | 2.67B |
| Cash, Cash Equivalents and Short-Term Investments | 416.97M | 330.01M | 735.06M | 611.90M | 308.35M | 279.33M |
| Total Debt | 0.00 | 2.17M | 51.90M | 72.80M | 19.08M | 34.76M |
| Total Liabilities | -7.39B | 757.59M | 945.90M | 659.02M | 700.96M | 509.90M |
| Stockholders Equity | 7.39B | 7.31B | 4.47B | 3.49B | 2.62B | 2.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -73.46M | 494.76M | 887.62M | -91.37M | -149.48M |
| Operating Cash Flow | 0.00 | 693.34M | 973.81M | 1.08B | 133.75M | 92.59M |
| Investing Cash Flow | 0.00 | -2.73B | -468.50M | -1.03B | -7.44M | -65.32M |
| Financing Cash Flow | 0.00 | 1.76B | -239.11M | -64.39M | -56.59M | -44.42M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹33.22B | 31.89 | ― | 1.97% | -8.66% | -17.79% | |
67 Neutral | ₹29.53B | 15.86 | ― | ― | 2.59% | 33.99% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹29.16B | 42.66 | ― | 0.41% | 19.59% | 13.81% | |
57 Neutral | ₹32.35B | 15.86 | ― | ― | -12.76% | -17.59% | |
46 Neutral | ₹19.25B | ― | ― | ― | ― | ― | |
46 Neutral | ₹28.38B | ― | ― | 0.38% | -8.05% | -150.62% |
Fineotex Chemical Limited held an Extraordinary General Meeting (EGM) on October 25, 2025, via video conferencing, in compliance with the relevant provisions and circulars issued by the Ministry of Corporate Affairs and SEBI. The meeting was attended by key directors and members, including the Chairman and Managing Director, Surendrakumar Tibrewala, and other executive and non-executive directors, with a total of 50 members participating. The EGM proceedings were conducted to ensure adherence to regulatory requirements and to facilitate the company’s operational and strategic discussions.
Fineotex Chemical Limited held an Extraordinary General Meeting (EGM) on October 25, 2025, where all proposed resolutions were addressed. The meeting was conducted via video conferencing, and shareholders were provided with remote e-voting facilities. The primary resolution involved approving an increase in authorized share capital, which was passed without any opposition from the promoter group. The scrutinizer’s report confirmed the voting results, indicating strong shareholder support for the resolution.
Fineotex Chemical Limited has announced the closure of its trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. This measure is part of the company’s Code of Conduct to regulate, monitor, and report trading by insiders. The trading window closure is effective from September 24, 2025, until 48 hours after the conclusion of the Board Meeting on September 27, 2025. During this period, directors, designated employees, and their immediate relatives are prohibited from trading in the company’s securities. This move ensures adherence to regulatory requirements and maintains transparency in the company’s operations.